These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1726078)
1. Sandwich enzyme immunoassay for serum integrins using monoclonal antibodies. Katayama M; Kurome T; Yamamoto K; Uchida H; Hino F; Kato I Clin Chim Acta; 1991 Oct; 202(3):179-90. PubMed ID: 1726078 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of clinical significance of isoferritin by development of new monoclonal antibodies specific for acidic isoferritin. You SY; Zhang CY; Yi XP; Huang W Hybridoma; 2001 Aug; 20(4):243-8. PubMed ID: 11604110 [TBL] [Abstract][Full Text] [Related]
3. Elevated serum level of thioredoxin in patients with hepatocellular carcinoma. Miyazaki K; Noda N; Okada S; Hagiwara Y; Miyata M; Sakurabayashi I; Yamaguchi N; Sugimura T; Terada M; Wakasugi H Biotherapy; 1998; 11(4):277-88. PubMed ID: 9950104 [TBL] [Abstract][Full Text] [Related]
4. Serum vitronectin receptor in alcoholic liver disease: correlation with fibronectin receptor and morphological features. Yamauchi M; Mizuhara Y; Toda G Alcohol Alcohol Suppl; 1993; 1A():37-43. PubMed ID: 7511380 [TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of anti-GP73 monoclonal antibodies and development of double-antibody sandwich ELISA. Li QW; Chen HB; Li ZY; Shen P; Qu LL; Gong LL; Xu HP; Pang L; Si J Asian Pac J Cancer Prev; 2015; 16(5):2043-9. PubMed ID: 25773808 [TBL] [Abstract][Full Text] [Related]
6. Development of a rapid, immunochromatographic strip test for serum asialo alpha1-acid glycoprotein in patients with hepatic disease. Lee EY; Kang JH; Kim KA; Chung TW; Kim HJ; Yoon DY; Lee HG; Kwon DH; Kim JW; Kim CH; Song EY J Immunol Methods; 2006 Jan; 308(1-2):116-23. PubMed ID: 16403512 [TBL] [Abstract][Full Text] [Related]
7. Serum des-gamma-carboxyprothrombin concentration determined by the avidin-biotin complex method in small hepatocellular carcinomas. Saitoh S; Ikeda K; Koida I; Tsubota A; Arase Y; Chayama K; Kumada H Cancer; 1994 Dec; 74(11):2918-23. PubMed ID: 7525036 [TBL] [Abstract][Full Text] [Related]
8. Soluble E-cadherin fragments increased in circulation of cancer patients. Katayama M; Hirai S; Kamihagi K; Nakagawa K; Yasumoto M; Kato I Br J Cancer; 1994 Mar; 69(3):580-5. PubMed ID: 8123491 [TBL] [Abstract][Full Text] [Related]
9. Concentration of serum laminin and type IV collagen in liver diseases assayed by a sandwich enzyme-immunoassay using monoclonal antibodies. Yokoya Y; Iwata K; Muragaki Y; Shiota C; Morimoto Y; Inoue M; Itoh H; Nishioka S; Ooshima A Clin Chim Acta; 1992 Sep; 210(1-2):109-18. PubMed ID: 1330375 [TBL] [Abstract][Full Text] [Related]
10. Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein. Iacovazzi PA; Trisolini A; Barletta D; Elba S; Manghisi OG; Correale M Clin Chem Lab Med; 2001 Oct; 39(10):961-5. PubMed ID: 11758611 [TBL] [Abstract][Full Text] [Related]
11. Serum 90K/MAC-2BP glycoprotein levels in hepatocellular carcinoma and cirrhosis. Correale M; Giannuzzi V; Iacovazzi PA; Valenza MA; Lanzillotta S; Abbate I; Quaranta M; Caruso ML; Elba S; Manghisi OG Anticancer Res; 1999; 19(4C):3469-72. PubMed ID: 10629637 [TBL] [Abstract][Full Text] [Related]
12. Murine T cells express a cell surface receptor for multiple extracellular matrix proteins. Identification and characterization with monoclonal antibodies. Maxfield SR; Moulder K; Koning F; Elbe A; Stingl G; Coligan JE; Shevach EM; Yokoyama WM J Exp Med; 1989 Jun; 169(6):2173-90. PubMed ID: 2471776 [TBL] [Abstract][Full Text] [Related]
13. Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases. Shirai Y; Kawata S; Tamura S; Ito N; Tsushima H; Takaishi K; Kiso S; Matsuzawa Y Cancer; 1994 May; 73(9):2275-9. PubMed ID: 7513247 [TBL] [Abstract][Full Text] [Related]
14. Distribution of the heterogeneity of des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma. Uehara S; Gotoh K; Handa H; Tomita H; Senshuu M J Gastroenterol Hepatol; 2005 Oct; 20(10):1545-52. PubMed ID: 16174072 [TBL] [Abstract][Full Text] [Related]
16. Elevation of serum MAGE-4 protein levels and prediction of hepatocellular carcinogenesis in patients with liver cirrhosis. Yutani S; Tanaka M; Mutsumoto H; Imai N; Sata M; Shichijo S; Harada M; Itoh K Jpn J Cancer Res; 2002 Apr; 93(4):453-8. PubMed ID: 11985796 [TBL] [Abstract][Full Text] [Related]
17. One step sandwich enzyme immunoassay for human type IV collagen using monoclonal antibodies. Obata K; Iwata K; Ichida T; Inoue K; Matsumoto E; Muragaki Y; Ooshima A Clin Chim Acta; 1989 May; 181(3):293-303. PubMed ID: 2547537 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers. Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164 [TBL] [Abstract][Full Text] [Related]
19. Abundance of immunologically active alanine aminotransferase in sera of liver cirrhosis and hepatocellular carcinoma patients. Kim HJ; Oh SW; Kim DJ; Choi EY Clin Chem; 2009 May; 55(5):1022-5. PubMed ID: 19264859 [TBL] [Abstract][Full Text] [Related]
20. The usefulness of determining des-gamma-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma. Mita Y; Aoyagi Y; Yanagi M; Suda T; Suzuki Y; Asakura H Cancer; 1998 May; 82(9):1643-8. PubMed ID: 9576283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]